CF
XBIT icon

Corebridge Financial’s XBiotech XBIT Stock Holding History

Corebridge Financial’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9,766
Closed -$31.6K – 2838
2025
Q1 		$31.6K Sell
9,766
-145
-1% -$500 ﹤0.01% 2827
2024
Q4 		$39.1K Sell
9,911
-748
-7% -$5.1K ﹤0.01% 2883
2024
Q3 		$82.4K Buy
10,659
+704
+7% +$4.63K ﹤0.01% 2706
2024
Q2 		$51.3K Buy
+9,955
New +$76.8K ﹤0.01% 2888

Other funds holding XBIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Corebridge Financial's XBIT Position: Q2 2025 in Review

Corebridge Financial sold out of XBiotech (XBIT) in Q2 2025, closing a stake of 9,766 shares — an estimated $31.6K sold.

Corebridge Financial first reported a position in XBIT in Q2 2024 and held it in 4 quarters. The position peaked at $82.4K in Q3 2024. 53 funds tracked by Wall St. Rank hold XBIT as of Q2 2025.

  • Corebridge Financial reported no remaining XBiotech position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 9,766 XBiotech shares in Q2 2025, an estimated $31.6K.
  • Corebridge Financial first reported a position in XBiotech in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's XBiotech position peaked at $82.4K in Q3 2024.
  • 53 funds tracked by Wall St. Rank held XBiotech as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.